Table 2.

Overview of measures and assessment points

Measure (instrument)	Assessment points
	t0	t1	t2	t3	t4
Socio-demographics (e-survey)	X
DSM-IV axis I and II disorders (e-survey)	X
Daily functioning (e-survey)	X
Personality traits (e-survey)	X
Clinical measures (e-survey)	X
Suicide plan and/or suicide attempt(s) (e-survey)	X
Childhood maltreatment and domestic violence (e-survey)	X
Academic experiences and functioning, participation in athletic and extracurricular activities (e-survey)	X
Information about lifetime and 12-month use of mental healthcare services (e-survey)	X
Depressive symptoms (PHQ-9)	X		X	X	X
Anxiety symptoms (GAD-7)	X		X	X	X
MINI-International Neuropsychiatric Interview		X			X
Quality of life (EQ-5D)		X	X	X	X
Satisfaction with treatment (CSQ-8)			X
Presenteeism (PSS)		X	X	X	X
Educational achievement		X	X	X	X
Study dropout			X	X	X
Use of regular care			X	X	X

CSQ-8, Client Satisfaction Questionnaire—8 items; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, fourth edition; EQ-5D, EuroQol—five dimensions; GAD-7, Generalised Anxiety Disorder scale—7 items; PHQ-9, Patient Health Questionnaire—9 items; PSS, Presenteeism Scale for Students; RCT, randomised controlled trial; t0, screening (total cohort); t1, baseline (RCT); t2, post-treatment (RCT); t3, 6 months post-randomisation (RCT); t4, 12 months post-randomisation (RCT); t5, 12 months after t0 (total cohort); t6, 24 months after t0 (total cohort).